MANILA, Philippines — Even though the Food and Drug Administration (FDA) has granted China-based drugmaker Sinovac’s Covid-19 vaccine an emergency use authorization, it is not recommended to be administered on healthcare workers and senior citizens, who are the top prioritypopulation for the government’s vaccination program.
The FDA on Monday announced that it has granted an EUA to Sinovac, a day before the donated shipment of 600,000 vaccine doses from China is set to arrive.
FDA Director General Eric Domingo said the vaccine’s efficacy rate on healthcare workers stands at 50.4%, which makes it not the best vaccine to be given to medical frontliners who are exposed to Covid-…
Keep on reading: Despite EUA, FDA advises vs using Sinovac on healthcare workers, seniors due to low efficacy